Group One Trading
LABD icon

Group One Trading’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Group One Trading’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$425K Sell
26,100
-20,600
-44% -$390K ﹤0.01% 3492
2025
Q4 		$984K Sell
46,700
-15,500
-25% -$420K ﹤0.01% 2895
2025
Q3 		$2.52M Buy
+62,200
New +$3.6M ﹤0.01% 2081

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Group One Trading's LABD Position: Q4 2025 in Review

Group One Trading sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q4 2025, closing a stake of 3,196 shares — an estimated $86.7K sold.

Group One Trading first reported a position in LABD in Q2 2025 and held it in 2 quarters. The position peaked at $337K in Q2 2025. 17 funds tracked by Wall St. Rank hold LABD as of Q4 2025.

  • Group One Trading reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 3,196 Direxion Daily S&P Biotech Bear 3X ETF shares in Q4 2025, an estimated $86.7K.
  • Group One Trading first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2025 and held it in 2 quarters.
  • Group One Trading's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $337K in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.